Hemostatic abnormalities in endocrine and metabolic disorders

M Franchini, G Lippi, F Manzato… - European journal of …, 2010 - academic.oup.com
The hemostatic balance is a complex system where the delicate equilibrium is regulated by
several factors, including hormones. This review summarizes current knowledge of the …

Hedgehog signalling in endocrine development and disease

PJ King, L Guasti, E Laufer - Journal of Endocrinology, 2008 - joe.bioscientifica.com
The present study aimed to examine whether transplacental exposure to progesterone
caused male reproductive abnormalities and whether the changes can be reversed after …

Tissue factor pathway Inhibitor‐1 is a valuable marker for the prediction of deep venous thrombosis and tumor metastasis in patients with lung cancer

X Fei, H Wang, W Yuan, M Wo… - BioMed research …, 2017 - Wiley Online Library
Activation of blood coagulation contributes to cancer progression. Tissue factor pathway
inhibitor‐1 (TFPI‐1) is the main inhibitor of extrinsic coagulation pathway. The aim of this …

Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers

P Farahnak, G Lärfars, M Sten-Linder… - The Journal of Clinical …, 2011 - academic.oup.com
Context: The extent and clinical significance of cardiovascular (CV) abnormalities
associated with mild primary hyperparathyroidism (PHPT) are still matters for discussion …

The calcium-clot connection: investigating the association between primary hyperparathyroidism and acute venous thromboembolism

G Khattar, FS Siddiqui, R Grovu, SA Baker… - Journal of Thrombosis …, 2024 - Springer
Primary hyperthyroidism (PHPT) is a relatively uncommon disease and leads to increased
calcium levels. Ionized calcium, known as clotting Factor IV, may lead to overt coagulation …

[HTML][HTML] The relationship between primary hyperparathyroidism and thrombotic events: report of three cases and a review of potential mechanisms

T Koufakis, V Antonopoulou, M Grammatiki… - … -Oncology and Stem …, 2018 - ncbi.nlm.nih.gov
We have described three uncommon cases of patients who presented with clinical
thrombotic events (stroke, pulmonary embolism and deep venous thrombosis) during the …

[PDF][PDF] An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis

E Heylen, J Willemse, D Hendriks - Front Biosci, 2011 - article.imrpress.com
Since its discovery more than 20 years ago, a lot has been revealed about the biochemistry
and physiological behaviour of carboxypeptidase U (CPU). Recent advances in CPU …

Arterial and venous thrombosis in endocrine diseases

B van Zaane, DJF Stuijver, A Squizzato… - … in thrombosis and …, 2013 - thieme-connect.com
Endocrine diseases have been associated with cardiovascular events. Both altered
coagulation and fibrinolysis markers and thrombotic disorders have been described in …

[HTML][HTML] Coagulation and fibrinolysis in hyperparathyroidism secondary to vitamin D deficiency

LPB Elbers, M Wijnberge, JCM Meijers… - Endocrine …, 2018 - ec.bioscientifica.com
Results 59 patients with VIDD of which 34 had secondary HPT and 36 controls were
included. After 2 months of suppletion, vitamin D increased by 399%(VIDD with HPT) …

[HTML][HTML] Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality

SH Kong, JM Bae, JH Kim, SW Kim… - Endocrinology and …, 2024 - synapse.koreamed.org
Background Parathyroid adenoma (PA) is a common endocrine disease linked to multiple
complications, but the pathophysiology of the disease remains incompletely understood …